Health Care Business Group

Size: px
Start display at page:

Download "Health Care Business Group"

Transcription

1 Health Care Business Group Joaquin Delgado, Executive Vice President December 17, M. All Rights Reserved.

2 2 3M CONFIDENTIAL M. All Rights Reserved.

3 Saving and improving lives around the world Number of deaths per year in U.S. from preventable hospital infections 87,000 People who suffer from asthma, and many breathe easier with 3M inhalers 150 million 3 million 300+ million Healthy and beautiful smiles, thanks to 3M dental restoratives & orthodontic solutions 100+ million 3M technologybased solutions improve health outcomes and reduce costs People die each year from food poisoning People who suffer from diabetes and other chronic illnesses; many helped by our solutions that help protect & restore skin integrity 3 Investor M Meeting Outlook Meeting, December December 17, , 2013

4 Agenda Business Overview and Market Landscape Strategic Playbook Developed and Developing Markets Opportunities Our Technologies & Portfolio 4 Investor M Meeting Outlook Meeting, December December 17, , 2013

5 3M Health Care Businesses Preventing Healthcare Associated Infections Innovating for Wound and Skin Care and Vascular Access Securement Improving Healthcare Efficiency, Quality and Reimbursement Making Smiles Healthy and Beautiful Customizing Pharmaceutical Drug Delivery Solutions Monitoring Food Safety Infection Prevention Critical & Chronic Care Health Information Systems Oral Care Drug Delivery Systems Food Safety A synergistic portfolio with breadth and depth across the healthcare industry 5 Investor M Meeting Outlook Meeting, December December 17, , 2013

6 The Health Care Business generates solid and consistent profitable growth $6.0 $4.0 $2.0 Sales CAGR of 5% $B $5.0 $5.1 $5.4 $4.3 $4.3 $4.5 Drug Delivery 9% Health Info Sys 11% Sales by Business 2013e Food Safety 5% Infection Prevention 29% $ e Critical & Chronic Care 21% Oral Care 25% $2.0 $B Operating Income CAGR of 7% Sales by Geography 2013e LAC 11% $1.0 $1.2 $1.3 $1.4 $1.5 $1.6 $1.7 APAC 16% U.S. 43% $ e Europe 30% 78% Developed Economies; 22% Developing 6 Investor M Meeting Outlook Meeting, December December 17, , 2013

7 3M Health Care Business Group portfolio strengths and synergies Technology Platforms Business Group Divisions Brand Food Safety Health Information Systems Medical Oral Care Supply Chain Drug Delivery Systems Global Presence Leveraging 3M s core strengths to provide total solutions for the healthcare industry 7 Investor M Meeting Outlook Meeting, December December 17, , 2013

8 Healthcare is a large, global growth opportunity Large, Growing Global Healthcare Market Global Market Penetration Opportunity $383B $92B $5B $7T Developed Countries Developing Countries 3M Sales Healthcare Addressable Market *Source: Medical etrack and Espicom 2012 $USD Growth WW Expenditures $7.0T 4.6% Developed Countries Expenditures Developing Countries Expenditures $5.4T 2.9% $1.6T 9.8% and we are uniquely positioned to gain market share in both Developed and Developing countries 8 Investor M Meeting Outlook Meeting, December December 17, , 2013

9 The Healthcare landscape Key Mega Trends Increased demand for access to Healthcare around the world People living longer Increased incidence of chronic diseases Use of comprehensive health data becoming more ubiquitous Advances in biologics and regenerative medicine Global Forces Shaping the Market More Access Improved Quality & Better Clinical Outcomes Healthcare Delivery at Lower Cost Solutions-based Technology Development Industry Success Enablers Prevention Digitization Shift to Lower Cost Delivery Sites Evidence-Based Solutions 9 Investor M Meeting Outlook Meeting, December December 17, , 2013

10 Business Overview and Market Landscape Strategic Playbook Developed and Developing Markets Opportunities Our Technologies & Portfolio 10 Investor M Meeting Outlook Meeting, December December 17, , 2013

11 3M Health Care Business Group strategic playbook 3M Strategies Playbook Expand Relevance to our Customers and our Presence in the Marketplace Gain Profitable Market Share and Accelerate Market Penetration Everywhere Accelerate growth in developing countries Gain profitable market share in developed countries Growth Invest in Innovation: Invigorate Existing Market Opportunities and Focus on Emerging Megatrends People & Capabilities R&D Invest in Innovation, Market Coverage and Localization Build High Performing and Diverse Global Talent Portfolio Prioritize Platforms and Geographies Intensify Capabilities to Achieve Regional Self-Sufficiency Drive Consistent Superior Levels of Operational Excellence Operational Excellence Liberate Funds for Investment 11 Investor M Meeting Outlook Meeting, December December 17, , 2013

12 Business Overview and Market Landscape Strategic Playbook Developed and Developing Markets Opportunities Our Technologies & Portfolio 12 Investor M Meeting Outlook Meeting, December December 17, , 2013

13 Gaining profitable market share in developed countries Priorities Key Platforms to Maximize Customer Relevancy Medical Health Info. Systems Oral Care Drug Delivery Food Safety Expand Coverage Across the Continuum of Care Align Portfolio to Targeted Care Delivery Points Vascular Access Skin Integrity Advanced Wound Care 360 Encompass TM Procedure-Based Solutions Digital Materials Prevention Inhalation Drug Delivery Molecular Detection Systems Increase Number of New-to-the-World Products Securement Patient Warming Healthcare Analytics Digital Ortho Clarity TM Ceramics Transdermal Drug Delivery Hygiene Monitoring Sterilization Incognito TM 13 Investor M Meeting Outlook Meeting, December December 17, , 2013

14 Expanding coverage across the continuum of care (USA) Hospital Surgery Center Wound Clinic Long-term Acute Care Physician Office Extended Care Home Health Oral Care 100% 3M USA Penetration Rates 80% 60% 40% 20% 0% 3M Penetration Rate Addressable Market Opportunity Upside in the USA and significant opportunity to expand into other developed markets 14 Investor M Meeting Outlook Meeting, December December 17, , 2013

15 Building growth faster and more productively in developing countries Expand Coverage Advance Standards of Care Tailor Portfolio Invest in Commercialization Competencies Targeted expansion to increase sales coverage Active participation in advancing healthcare standards Expand local laboratory and manufacturing capabilities Enhance competence in sales, marketing, clinical and regulatory areas Continue to strengthen our commercialization and market development capabilities 15 Investor M Meeting Outlook Meeting, December December 17, , 2013

16 Developing markets strategy produces results China 15% growth Local Lab Increasing R&D and technical service competencies Developing localized and new-to-theworld products Localizing clinical research Local Manufacturing Medical products plant Orthodontic products plant Brazil 21% growth Increasing R&D and technical service competencies Expanding R&D capabilities to enhance localized product pipeline Localizing clinical research Oral Care products plant Medical products plant Growth rates are Sept YTD Organic Local Currency 16 Investor M Meeting Outlook Meeting, December December 17, , 2013

17 Business Overview and Market Landscape Strategic Playbook Developed and Developing Markets Opportunities Our Technologies & Portfolio 17 Investor M Meeting Outlook Meeting, December December 17, , 2013

18 Tailoring our new product development strategy Developed Countries: Innovation Developing Countries: Penetration Shift innovation pipeline towards Adjacent and Transformational Products Localize core portfolio and advance new-to-the market local product development Transformational Products Replacement New Products New-to-Market Products Product Localization 18 Investor M Meeting Outlook Meeting, December December 17, , 2013

19 Healthcare Megatrends 3M Technologies Healthcare megatrends and 3M technologies drive innovation Increased demand for access to Healthcare around the world Earlier detection of pathogens in Healthcare facilities and food streams People living longer Increased incidence of chronic diseases Preventing harmful and costly Healthcare associated infections Use of comprehensive health data becoming more ubiquitous Advances in biologics and regenerative medicine Providing cost-effective therapeutic solutions in critical and chronic care Digitization of information to improve accuracy and compliance, and make better decisions 19 Investor M Meeting Outlook Meeting, December December 17, , 2013

20 High impact R&D programs: creating the future Detection Prevention Intervention Digitization Novel Food Safety Detection Technologies In-Office Preventive Dental Care Biologic Wound Care Integrated Oral Digital Technologies Toxins, Allergens, and Residues Market opportunity >$700M New materials and devices to identify and prevent oral conditions Market opportunity >$150M Bio-active wound closure, accelerated healing Market opportunity $650M Transform analogue procedures to digital Market opportunity $750M Enabling Novel Surgical Solutions Healthcare Data Analytics Assisting surgeons in open and minimally invasive procedures Market opportunity $500M Improve quality and mitigate risk in care delivery Market opportunity $3.7B 20 Investor M Meeting Outlook Meeting, December December 17, , 2013

21 Acquisitions have been important to Healthcare s success Code 3 Corporation (Health Information) (Dental products) (Orthodontic products for developing markets) (Computer-assisted coding) (Orthodontic products) (Microbiological food safety testing) (Patient warming) Combining acquisitions with organic innovation to expand the breadth and depth our portfolio 21 Investor M Meeting Outlook Meeting, December December 17, , 2013

22 We acquired Arizant Healthcare in 2010 Acquisition combined with 3M capabilities drives profitable, global growth Forced Air Patient Warming Gown Forced Air Warming Blankets Fluid Warming Multiple new products launches since acquisition and strong future pipeline Expanding solutions beyond traditional operating room setting Expanding the business across 3M s footprint; products now sold in 70+ countries versus 36 countries when acquired Core Temperature Monitoring New product launch since acquisition 2013e Local Currency Growth % Developed Countries Developing Countries 6% 15% Exceeding original growth forecast Delivering savings Revenue synergies taking hold 22 Investor M Meeting Outlook Meeting, December December 17, , 2013

23 3M is well positioned to thrive in a dynamic healthcare market Attractive portfolio Global footprint Arsenal of leading technologies Growth funded by operational excellence An inspired, dedicated team Improving Every Life each and every day 23 Investor M Meeting Outlook Meeting, December December 17, , 2013

24 2013 3M. All Rights Reserved.

Inge Thulin. Chairman of the Board, President & Chief Executive Officer. December 16, M. All Rights Reserved.

Inge Thulin. Chairman of the Board, President & Chief Executive Officer. December 16, M. All Rights Reserved. Inge Thulin Chairman of the Board, President & Chief Executive Officer December 16, 2014 Agenda Today s Headlines 3M Playbook 2013 2017 5-Year Plan Update 3M Key Levers Portfolio Management Investing in

More information

Mike Roman. Chief Operating Officer & Executive Vice President. Bank of America Merrill Lynch Global Industrials Conference.

Mike Roman. Chief Operating Officer & Executive Vice President. Bank of America Merrill Lynch Global Industrials Conference. Mike Roman Chief Operating Officer & Executive Vice President Bank of America Merrill Lynch Global Industrials Conference March 22, 2018 1 Building strength-on-strength and positioned for growth 2017 Executing

More information

Safety of the Food Supply - a Worldwide Problem

Safety of the Food Supply - a Worldwide Problem Investors Conference March 17, 2011 Executing the 3M Playbook in the Food Safety Market Francine Savage Safety of the Food Supply - a Worldwide Problem Food recalls are an everyday event: 3 million people

More information

Inge Thulin. Chairman of the Board, President and CEO. Bernstein Strategic Decisions Conference. June 1, 2017

Inge Thulin. Chairman of the Board, President and CEO. Bernstein Strategic Decisions Conference. June 1, 2017 Inge Thulin Chairman of the Board, President and CEO Bernstein Strategic Decisions Conference June 1, 2017 1 Forward looking statement This presentation contains forward-looking information about 3M's

More information

BD Strategy Overview. Advancing the world of health. Vincent A. Forlenza Chairman, Chief Executive Officer and President

BD Strategy Overview. Advancing the world of health. Vincent A. Forlenza Chairman, Chief Executive Officer and President BD Strategy Overview Advancing the world of health Vincent A. Forlenza Chairman, Chief Executive Officer and President BD IS AT THE VERY BEGINNING OF AN AMAZING JOURNEY WHERE WE CAN HAVE A PROFOUND IMPACT

More information

New Cardinal Health (Post-Spin)

New Cardinal Health (Post-Spin) New Cardinal Health (Post-Spin) George Barrett Vice Chairman and Chief Executive Officer Healthcare Supply Chain Services and Chief Executive Officer Cardinal Health, Inc. (post-spin) January 14, 2009

More information

North America Surgical Sutures Market Outlook to 2020

North America Surgical Sutures Market Outlook to 2020 North America Surgical Sutures Market Outlook to 2020 Reference Code: GDMECR0234DB Publication Date: October 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 4 1.2 List of

More information

Japan Negative Pressure Wound Therapy (NPWT) Market Outlook to 2020

Japan Negative Pressure Wound Therapy (NPWT) Market Outlook to 2020 Japan Negative Pressure Wound Therapy (NPWT) Market Outlook to 2020 Reference Code: GDMECC0963DB Publication Date: October 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables...

More information

SAMPLE. North America Trauma Fixation Procedures Outlook to 2020

SAMPLE. North America Trauma Fixation Procedures Outlook to 2020 North America Trauma Fixation Procedures Outlook to 2020 Reference Code: GDMECR0008PDB Publication Date: March 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 3 1.2 List

More information

France Spinal Surgery Procedures Outlook to 2020

France Spinal Surgery Procedures Outlook to 2020 France Spinal Surgery Procedures Outlook to 2020 Reference Code: GDMECC0027PDB Publication Date: March 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 3 1.2 List of Figures...

More information

Brazil Gastric Balloon Procedures Outlook to 2020

Brazil Gastric Balloon Procedures Outlook to 2020 Brazil Gastric Balloon Procedures Outlook to 2020 Reference Code: GDMECC0472PDB Publication Date: July 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 3 1.2 List of Figures...

More information

34 th Annual J.P. Morgan Healthcare Conference

34 th Annual J.P. Morgan Healthcare Conference 34 th Annual J.P. Morgan Healthcare Conference Vincent A. Forlenza Chairman, Chief Executive Officer and President January 13, 2016 Forward-Looking Statements These materials include forward-looking statements

More information

SAMPLE. Mexico Orthopedic Prosthetics Market Outlook to Reference Code: GDMECC0156DB. Publication Date: February 2014

SAMPLE. Mexico Orthopedic Prosthetics Market Outlook to Reference Code: GDMECC0156DB. Publication Date: February 2014 Mexico Orthopedic Prosthetics Market Outlook to 2020 Reference Code: GDMECC0156DB Publication Date: February 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 3 1.2 List of

More information

BRIC Surgical Sutures Market Outlook to 2020

BRIC Surgical Sutures Market Outlook to 2020 BRIC Surgical Sutures Market Outlook to 2020 Reference Code: GDMECR0270DB Publication Date: October 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 5 1.2 List of Figures...

More information

United Kingdom Tissue Engineered - Skin Substitutes Market Outlook to 2020

United Kingdom Tissue Engineered - Skin Substitutes Market Outlook to 2020 United Kingdom Tissue Engineered - Skin Substitutes Market Outlook to Reference Code: GDMECC0860DB Publication Date: October 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables...

More information

Cardinal Health overview and strategic priorities

Cardinal Health overview and strategic priorities Cardinal Health overview and strategic priorities Steve Inacker President, Channel Management Medical Segment Copyright 2011, Cardinal Health, Inc. or one of its subsidiaries. All rights reserved. Cardinal

More information

Spain Knee Replacement Procedures Outlook to 2020

Spain Knee Replacement Procedures Outlook to 2020 Spain Knee Replacement Procedures Outlook to 2020 Reference Code: GDMECC0052PDB Publication Date: March 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 3 1.2 List of Figures...

More information

Germany Tissue Engineered - Skin Substitutes Market Outlook to 2020

Germany Tissue Engineered - Skin Substitutes Market Outlook to 2020 Germany Tissue Engineered - Skin Substitutes Market Outlook to 2020 Reference Code: GDMECC0884DB Publication Date: October 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables...

More information

J.P. Morgan Healthcare Conference January 10, 2018

J.P. Morgan Healthcare Conference January 10, 2018 J.P. Morgan Healthcare Conference January 10, 2018 Safe Harbor This presentation is intended to be disclosure through methods reasonably designed to provide broad, non-exclusionary distribution to the

More information

France Pressure Relief Devices Market Outlook to 2020

France Pressure Relief Devices Market Outlook to 2020 France Pressure Relief Devices Market Outlook to 2020 Reference Code: GDMECC0869DB Publication Date: October 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 3 1.2 List of

More information

Consumer Business Group

Consumer Business Group Consumer Business Group Michael G. Vale Executive Vice President 3M Investor Day March 29, 2016 Agenda Business overview External market context International growth opportunity Operating model for success

More information

H.C. Shin. March 17, Executive Vice President, International Operations M. All Rights Reserved.

H.C. Shin. March 17, Executive Vice President, International Operations M. All Rights Reserved. H.C. Shin Executive Vice President, International Operations March 17, 2015 Forward Looking Statements This presentation contains forward-looking information about 3M's financial results and estimates

More information

Brazil Capsule Endoscopy Procedures Outlook to 2020

Brazil Capsule Endoscopy Procedures Outlook to 2020 Brazil Capsule Endoscopy Procedures Outlook to 2020 Reference Code: GDMECC0469PDB Publication Date: July 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 3 1.2 List of Figures...

More information

SAMPLE. South Korea MRI Systems Market Outlook to Reference Code: GDMECC0287DB. Publication Date: March 2014

SAMPLE. South Korea MRI Systems Market Outlook to Reference Code: GDMECC0287DB. Publication Date: March 2014 South Korea MRI Systems Market Outlook to 2020 Reference Code: GDMECC0287DB Publication Date: March 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 3 1.2 List of Figures...

More information

China Biopsy Devices Market Outlook to 2020

China Biopsy Devices Market Outlook to 2020 China Biopsy Devices Market Outlook to 2020 Reference Code: GDMECC0645DB Publication Date: July 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 4 1.2 List of Figures... 5

More information

United States Orthopedic Bone Cement and Casting Materials Market. Outlook to 2020

United States Orthopedic Bone Cement and Casting Materials Market. Outlook to 2020 United States Orthopedic Bone Cement and Casting Materials Market Reference Code: GDMECC0008DB Publication Date: March 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 4 1.2

More information

South Korea Ultrasound Systems Market Outlook to 2020

South Korea Ultrasound Systems Market Outlook to 2020 South Korea Ultrasound Systems Market Outlook to 2020 Reference Code: GDMECC0289DB Publication Date: March 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 4 1.2 List of Figures...

More information

Jefferies 2014 Global Healthcare Conference June 3, 2014 NYSE: Q

Jefferies 2014 Global Healthcare Conference June 3, 2014 NYSE: Q Jefferies 2014 Global Healthcare Conference June 3, 2014 NYSE: Q Copyright 2013 Quintiles Forward Looking Statements and Use of Non-GAAP Financial Measures This presentation contains forward-looking statements

More information

Jefferies Healthcare Conference

Jefferies Healthcare Conference Jefferies Healthcare Conference Align Technology, Inc. Shirley Stacy, VP Investor Relations and Corporate Communications June 3, 2014 2014 Align Technology, Inc. All rights reserved. 1 2014 Align Technology,

More information

itero - Scan Every Patient at Every Visit

itero - Scan Every Patient at Every Visit itero - Scan Every Patient at Every Visit / YUVAL SHAKED Vice President, Managing Director, itero Scanner and Services / New York, May 23, 2018 2018 Align Technology, Inc. 1 Forward Looking Statement During

More information

Anika Therapeutics, Inc.

Anika Therapeutics, Inc. Anika Therapeutics, Inc. Jefferies Global Healthcare Conference June 4, 2015 Safe Harbor Statement The statements made in this presentation that are not statements of historical fact are forward looking

More information

UPS Healthcare Supply Chain Vital Signs

UPS Healthcare Supply Chain Vital Signs UPS Study Executive September 2017 START 2017 UPS Survey 2017 United Parcel Service of America, Inc. 1 An industry growing more complex: managing competition, compliance and costs Pharmacies are grappling

More information

Innovation in medical devices as response to Europe's healthcare challenges. Industry's viewpoint

Innovation in medical devices as response to Europe's healthcare challenges. Industry's viewpoint HIGH-LEVEL CONFERENCE "EXPLORING INNOVATIVE HEALTHCARE THE ROLE OF MEDICAL TECHNOLOGY INNOVATION AND REGULATION" Innovation in medical devices as response to Europe's healthcare challenges Industry's viewpoint

More information

Philips: a focused leader in HealthTech

Philips: a focused leader in HealthTech Philips: a focused leader in HealthTech Frans van Houten, CEO Royal Philips 36th Annual J.P. Morgan Healthcare Conference, San Francisco, USA January 9, 2018 Important information Forward looking statements

More information

Global In-Vitro Diagnostic Market Report

Global In-Vitro Diagnostic Market Report Global In-Vitro Diagnostic Market Report ----------------------------------------------------- 2013 Executive Summary The process of performing a diagnostic test outside of a living organism in an artificial

More information

Santen Acquisition of InnFocus, Developer of MicroShunt Glaucoma Implant Device

Santen Acquisition of InnFocus, Developer of MicroShunt Glaucoma Implant Device Santen Acquisition of InnFocus, Developer of MicroShunt Glaucoma Implant Device Akira Kurokawa President & CEO August 2, 2016 Copyright 2016 Santen Pharmaceutical Co., Ltd. All rights reserved. 1 External

More information

Improve your probability. of success

Improve your probability. of success Improve your probability of success FROM PIPELINE TO PORTFOLIO TO POPULATION HEALTH TM Creating a healthier world will require the industry s best thinking and resources. It will also demand working together

More information

Capturing the HealthTech opportunity

Capturing the HealthTech opportunity Capturing the HealthTech opportunity Frans van Houten, CEO Royal Philips JP Morgan European Capital Goods Conference June 11, 2015 Philips: strong starting positions in health and well-being Businesses

More information

2009 INVESTOR DAY. Medical. Allan Ross President Medical December 17, 2009

2009 INVESTOR DAY. Medical. Allan Ross President Medical December 17, 2009 2009 INVESTOR DAY Medical Allan Ross President Medical December 17, 2009 Pall Life Sciences - Medical BioPharmaceuticals Medical 24% 17% 38% Energy, Water & Process Technologies 9% 12% Microelectronics

More information

Managing Across the Care Continuum: Distribution to Alternate Sites

Managing Across the Care Continuum: Distribution to Alternate Sites Managing Across the Care Continuum: Distribution to Alternate Sites April 23, 2014 1 2014, MedAssets, Inc. All rights reserved. MedAssets. Not to be reprinted without permission. For non-commercial use

More information

Global Low Temperature Sterilization Market: Industry Analysis & Outlook

Global Low Temperature Sterilization Market: Industry Analysis & Outlook Industry Research by Koncept Analytics Global Low Temperature Sterilization Market: Industry Analysis & Outlook ----------------------------------------- February 2018 1 Executive Summary Sterilization

More information

TRUSTED GLOBAL LEADER

TRUSTED GLOBAL LEADER TRUSTED GLOBAL LEADER FULL YEAR RESULTS YEAR ENDED 30 JUNE 2017 OVERVIEW FY17 Highlights Gross profit* STRONG FULL YEAR PERFORMANCE FY15 53.7M ALL OPERATIONS CONTRIBUTING TO GOOD LEVELS OF ORGANIC GROWTH

More information

Global Pre-filled Syringes Market-Data, Analysis and Forecast to 2024

Global Pre-filled Syringes Market-Data, Analysis and Forecast to 2024 Global Pre-filled Syringes Market-Data, Analysis and Forecast to 2024 Pharmaceutical, healthcare, commercial and strategic developments in the Global Pre-Filled Syringes Market 2014-2024 www.gmrdata.com

More information

Global IVD Market

Global IVD Market Global IVD Market ----------------------------------------------------- 2014 Executive Summary An in-vitro diagnostic test is performed outside of a human body in an artificial environment (e.g. laboratory).

More information

Anika Therapeutics, Inc.

Anika Therapeutics, Inc. Anika Therapeutics, Inc. Canaccord Genuity 34th Annual Growth Conference August 14 th, 2014 Safe Harbor Statement The statements made in this presentation, which are not statements of historical fact,

More information

Tecan Group 34 th Annual J.P. Morgan Healthcare Conference DR. DAVID MARTYR, CEO JANUARY 14, 2016 SAN FRANCISCO, USA

Tecan Group 34 th Annual J.P. Morgan Healthcare Conference DR. DAVID MARTYR, CEO JANUARY 14, 2016 SAN FRANCISCO, USA Tecan Group 34 th Annual J.P. Morgan Healthcare Conference DR. DAVID MARTYR, CEO JANUARY 14, 2016 SAN FRANCISCO, USA Safe Habor Statement All statements in this presentation not referring to historical

More information

2009 INVESTOR DAY. BioPharmaceuticals. Ken Frank President BioPharmaceuticals December 17, Sustainable, Profitable Growth

2009 INVESTOR DAY. BioPharmaceuticals. Ken Frank President BioPharmaceuticals December 17, Sustainable, Profitable Growth 2009 INVESTOR DAY BioPharmaceuticals Ken Frank President BioPharmaceuticals December 17, 2009 Sustainable, Profitable Growth Life Sciences FY 2009 Total Sales $2,329.2 (amounts shown in millions) BioPharmaceuticals

More information

Driving global scale and category leadership in Male Grooming. Caroline Clarke, CEO Personal Care

Driving global scale and category leadership in Male Grooming. Caroline Clarke, CEO Personal Care Driving global scale and category leadership in Male Grooming Caroline Clarke, CEO Personal Care 1 1 Key takeaways Our leadership position in Male Grooming is based on global scale and strong local relevance

More information

Building growth momentum through personal health solutions. Roy Jakobs Chief Business Leader Personal Health

Building growth momentum through personal health solutions. Roy Jakobs Chief Business Leader Personal Health Building growth momentum through personal health solutions Roy Jakobs Chief Business Leader Personal Health Key takeaways Our leading Personal Health innovations enable healthier lifestyles and support

More information

Cautions Concerning Forward-looking Statements

Cautions Concerning Forward-looking Statements 1 Cautions Concerning Forward-looking Statements These presentations contain forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995 regarding, among other things,

More information

Country Coverage. Regional Coverage. Global Coverage. Company Coverage

Country Coverage. Regional Coverage. Global Coverage. Company Coverage Medical Sterilization Equipment Market By Mode (High Temperature, Low Temperature, Radiation), Services (In-House, Contact), End-User Industry (2017 Edition): Forecast to 2022 By Mode of Sterilization

More information

QIAGEN Sample & Assay Technologies From Discovery to Patient

QIAGEN Sample & Assay Technologies From Discovery to Patient QIAGEN From Discovery to Patient New York, February 14 QIAGEN 2008 Analyst & Investor Day Peer Schatz, CEO -7- Forward Looking Statements Safe Harbor Statement: Certain of the statements contained in this

More information

Progress Report. Jouko Karvinen CEO of Medical Systems

Progress Report. Jouko Karvinen CEO of Medical Systems Progress Report Jouko Karvinen CEO of Medical Systems Forward Looking Statements Forward Looking Statements This document contains certain forward-looking statements with respect to the financial condition,

More information

SAMPLE. Bracco Imaging S.p.A.Market Share Analysis. Bracco Imaging S.p.A. Market Share Analysis GDME0639CDB / Published January 2013

SAMPLE. Bracco Imaging S.p.A.Market Share Analysis. Bracco Imaging S.p.A. Market Share Analysis GDME0639CDB / Published January 2013 Market Share Analysis Reference Code: GDME0639CDB Publication Date: January 2013 GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form Page 1 Table

More information

To Our. written over 70 years ago, unites & inspires the employees of Johnson & Johnson.

To Our. written over 70 years ago, unites & inspires the employees of Johnson & Johnson. March 2016 To Our Shareholders Alex Gorsky Chairman, Board of Directors and Chief Executive Officer This year at Johnson & Johnson, we are proud to celebrate 130 years of helping people everywhere live

More information

Investor Overview Presentation ADVANCING LIFE SCIENCE TOGETHER

Investor Overview Presentation ADVANCING LIFE SCIENCE TOGETHER Investor Overview Presentation ADVANCING LIFE SCIENCE TOGETHER Forward-Looking Statement Disclaimer In order to take advantage of the safe harbor provisions of the private securities litigation reform

More information

Enabling Growth. H.C. Shin Vice Chair and Executive Vice President. December 12, 2017

Enabling Growth. H.C. Shin Vice Chair and Executive Vice President. December 12, 2017 Enabling Growth H.C. Shin Vice Chair and Executive Vice President December 12, 2017 1 Agenda Business Transformation o Enhancing customer experience and 3M productivity Supply Chain roadmap Investing in

More information

R1 to Acquire Intermedix and Selected as RCM Services Provider for Ascension Physician Business

R1 to Acquire Intermedix and Selected as RCM Services Provider for Ascension Physician Business R1 to Acquire Intermedix and Selected as RCM Services Provider for Ascension Physician Business Investor Presentation February 26, 2018 Forward-Looking Statements and Non-GAAP Financial Measures This presentation

More information

Ascom Investor Presentation. May 2018

Ascom Investor Presentation. May 2018 Ascom Investor Presentation May 2018 Our Vision Ascom closes digital information gaps allowing for the best possible decisions anytime and anywhere 2 Ascom increases workflow productivity in Healthcare

More information

AVITA Medical RECELL System Health Economic Data Projects USD $28 Million in Annual Savings at a Single Major Burn Center Versus Standard of Care

AVITA Medical RECELL System Health Economic Data Projects USD $28 Million in Annual Savings at a Single Major Burn Center Versus Standard of Care ASX/News Release AVITA Medical RECELL System Health Economic Data Projects USD $28 Million in Annual Savings at a Single Major Burn Center Versus Standard of Care Additional data presented at ABA Annual

More information

2015 Investor Meeting

2015 Investor Meeting 2015 Investor Meeting New York City December 4, 2015 Safe Harbor Except for historical information, the matters discussed in this presentation may constitute forward-looking statements that involve risks

More information

NuVasive, Inc. Acquisition of Ellipse Technologies, Inc. January 5, 2016

NuVasive, Inc. Acquisition of Ellipse Technologies, Inc. January 5, 2016 NuVasive, Inc. Acquisition of Ellipse Technologies, Inc. January 5, 2016 Safe Harbor Statements Forward-looking information and non-gaap measures NuVasive, Inc. ( NuVasive, NUVA or the Company ) cautions

More information

CEO s Round Table June

CEO s Round Table June CEO s Round Table June 2009 0 Forward looking statements This presentation contains certain "forward-looking statements" within the meaning of the US Private Securities Litigation Reform Act of 1995. In

More information

Safety & Graphics Business Group

Safety & Graphics Business Group Safety & Graphics Business Group Frank Little, Executive Vice President December 16, 2014 Safety & Graphics is bringing the 3M Vision to life 3M Technology Advancing Every Company 3M Innovation Improving

More information

Capital Market Day June 12, 2012

Capital Market Day June 12, 2012 Capital Market Day 2012 June 12, 2012 Product Segments IV Drugs John Ducker Member of the Management Board President Region North America Capital Market Day Fresenius Kabi, June 12, 2012 Agenda 1 2 3 4

More information

UBS 2007 Global Life Sciences Conference. September 24, 2007

UBS 2007 Global Life Sciences Conference. September 24, 2007 UBS 2007 Global Life Sciences Conference September 24, 2007 Safe Harbor This presentation contains "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933 and Section

More information

PerkinElmer, Inc. JP Morgan Global Healthcare Conference. Robert Friel, Chairman and CEO January 14, 2015 HUMAN HEALTH ENVIRONMENTAL HEALTH

PerkinElmer, Inc. JP Morgan Global Healthcare Conference. Robert Friel, Chairman and CEO January 14, 2015 HUMAN HEALTH ENVIRONMENTAL HEALTH PerkinElmer, Inc JP Morgan Global Healthcare Conference Robert Friel, Chairman and CEO January 14, 2015 HUMAN HEALTH ENVIRONMENTAL HEALTH 2014 PerkinElmer FACTORS AFFECTING FUTURE PERFORMANCE & NON-GAAP

More information

2018 Investor Day Consumer Business Group

2018 Investor Day Consumer Business Group 2018 Investor Day Consumer Business Group Joaquin Delgado, Ph.D. Executive Vice President November 15, 2018 Agenda: Consumer Business Group 2018 Investor Day Nov 15, 2018 Overview Imagination & creativity

More information

Investor Presentation May 2018

Investor Presentation May 2018 Investor Presentation May 2018 FORWARD-LOOKING STATEMENTS Forward-Looking Statements Certain statements and information in this communication may be deemed to be forward-looking statements within the meaning

More information

Jefferies 2017 Global Healthcare Conference. June 7, 2017

Jefferies 2017 Global Healthcare Conference. June 7, 2017 Jefferies 2017 Global Healthcare Conference June 7, 2017 Forward-Looking Statements This document may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act

More information

DEMONSTRATING YOUR MEDICINE S VALUE TO ALL STAKEHOLDERS TRUSTED COMMERCIALIZATION AND MARKET ACCESS EXPERTISE

DEMONSTRATING YOUR MEDICINE S VALUE TO ALL STAKEHOLDERS TRUSTED COMMERCIALIZATION AND MARKET ACCESS EXPERTISE CATALYSTS DRIVING SUCCESSFUL DECISIONS IN LIFE SCIENCES DEMONSTRATING YOUR MEDICINE S VALUE TO ALL STAKEHOLDERS TRUSTED COMMERCIALIZATION AND MARKET ACCESS EXPERTISE WHEN COMMERCIALIZING A MEDICINE, IT

More information

Jefferies 2018 Global Healthcare Conference. June 7, 2018

Jefferies 2018 Global Healthcare Conference. June 7, 2018 Jefferies 2018 Global Healthcare Conference June 7, 2018 Forward-Looking Statements Statements in this presentation regarding the future financial and operating results, outlook, growth, prospects, business

More information

Teva Pharmaceutical Industries Ltd. J.P. Morgan Healthcare Conference. Kåre Schultz President and CEO January 7, 2019

Teva Pharmaceutical Industries Ltd. J.P. Morgan Healthcare Conference. Kåre Schultz President and CEO January 7, 2019 Teva Pharmaceutical Industries Ltd. J.P. Morgan Healthcare Conference Kåre Schultz President and CEO January 7, 2019 Cautionary Note Regarding Forward-Looking Statements 2 This presentation contains forward-looking

More information

MEDICATION DELIVERY. David Ferguson GM, Medication Delivery. May 21, 2018

MEDICATION DELIVERY. David Ferguson GM, Medication Delivery. May 21, 2018 MEDICATION DELIVERY David Ferguson GM, Medication Delivery May 21, 2018 Safe Harbor Statement This presentation includes forward-looking statements concerning Baxter s financial results, R&D pipeline,

More information

GE Growth Strategy. Business Development & Organic Growth. Hwang Soo President of GE Korea Feb. 12, 2008

GE Growth Strategy. Business Development & Organic Growth. Hwang Soo President of GE Korea Feb. 12, 2008 GE Growth Strategy Business Development & Organic Growth Hwang Soo President of GE Korea Feb. 12, 2008 This is GE We are World s Most Admired Company The only company listed in the Dow Jones Industrial

More information

STRYKER ANALYST MEETING. September 2014

STRYKER ANALYST MEETING. September 2014 STRYKER ANALYST MEETING September 2014 FORWARD LOOKING STATEMENT Certain statements made in the presentation may contain information that includes or is based on forward-looking statements within the meaning

More information

Globaldata. Publisher Sample

Globaldata.   Publisher Sample Globaldata http://www.marketresearch.com/globaldata-v3648/ Publisher Sample Phone: 800.298.5699 (US) or +1.240.747.3093 or +1.240.747.3093 (Int'l) Hours: Monday - Thursday: 5:30am - 6:30pm EST Fridays:

More information

Universal Biosensors, Inc.

Universal Biosensors, Inc. Universal Biosensors, Inc. ARBN 121 559 993 UBS Australian Healthcare Conference November 2011 1 Important Disclaimer This presentation is intended to provide a general outline only and is not intended

More information

Alliqua BioMedical Investor Presentation August 2017 NASDAQ: ALQA

Alliqua BioMedical Investor Presentation August 2017 NASDAQ: ALQA Alliqua BioMedical Investor Presentation August 2017 NASDAQ: ALQA Forward Looking Statements Safe Harbor Statement This presentation contains forward-looking statements. Forward-looking statements are

More information

A Leading Global Health Care Group

A Leading Global Health Care Group A Leading Global Health Care Group Frankfurt stock exchange: FRE US ADR program: FSNUY www.fresenius.com/investors General Presentation, Fresenius SE & Co. KGaA, Investor Relations Copyright, August 2016

More information

Pfizer To Acquire Hospira

Pfizer To Acquire Hospira For immediate release: February 5, 2015 Media Contact: Joan Campion (212) 733-2798 Investor Contact: Ryan Crowe (212) 733-8160 Pfizer To Acquire Hospira - Transaction will significantly enhance Pfizer

More information

Maximizing Market Access: THE 5 MOST CRITICAL QUESTIONS TO ASK WHEN LAUNCHING A SPECIALTY DRUGS

Maximizing Market Access: THE 5 MOST CRITICAL QUESTIONS TO ASK WHEN LAUNCHING A SPECIALTY DRUGS Maximizing Market Access: THE 5 MOST CRITICAL QUESTIONS TO ASK WHEN LAUNCHING A SPECIALTY DRUGS by Jan Nielsen, division president, Access & Patient Support Are You Asking the Right Questions? We ve all

More information

1 Table of Contents 1.1 List of Tables 1.2 List of Figures 2 Emerging Pharmaceutical Market - Indonesia and the Philippines -Introduction 3 Emerging

1 Table of Contents 1.1 List of Tables 1.2 List of Figures 2 Emerging Pharmaceutical Market - Indonesia and the Philippines -Introduction 3 Emerging 1 Table of Contents 1.1 List of Tables 1.2 List of Figures 2 Emerging Pharmaceutical Market - Indonesia and the Philippines -Introduction 3 Emerging Pharmaceutical Market - Indonesia and the Philippines

More information

Plumbing Products. Richard O Reagan / Group President, Global Plumbing

Plumbing Products. Richard O Reagan / Group President, Global Plumbing Plumbing Products Richard O Reagan / Group President, Global Plumbing Safe Harbor Statement This presentation contains statements that reflect our views about our future performance and constitute forward-looking

More information

Investor Presentation RBC Capital Markets Global Healthcare Conference February 22, 2017

Investor Presentation RBC Capital Markets Global Healthcare Conference February 22, 2017 Investor Presentation 2017 RBC Capital Markets Global Healthcare Conference February 22, 2017 Forward-Looking Statements This document may contain forward-looking statements within the meaning of the Private

More information

GSK Consumer Health Supplier Relationship Team (SRT) Concept. Yassine Laqbayli Supplier Interface Manager GSK AGENDA TOPICS

GSK Consumer Health Supplier Relationship Team (SRT) Concept. Yassine Laqbayli Supplier Interface Manager GSK AGENDA TOPICS GSK Consumer Health Supplier Relationship Team (SRT) Concept Yassine Laqbayli Supplier Interface Manager GSK AGENDA TOPICS Introduction to GSK Consumer Health Link between Supply Chain and Supplier Relationship

More information

Stephens Fall Investment Conference

Stephens Fall Investment Conference Stephens Fall Investment Conference November 8, 2017 Steven M. Klosk President & CEO Forward-Looking Statements This document may contain forward-looking statements within the meaning of the Private Securities

More information

MORGAN STANLEY LAGUNA CONFERENCE Dan Comas September 15, 2016

MORGAN STANLEY LAGUNA CONFERENCE Dan Comas September 15, 2016 MORGAN STANLEY LAGUNA CONFERENCE Dan Comas September 15, 2016 Forward Looking Statements Statements in this presentation that are not strictly historical, including any statements regarding events or developments

More information

Portada Victoria CAPITAL MARKETS DAY 25 JANUARY 2018

Portada Victoria CAPITAL MARKETS DAY 25 JANUARY 2018 Portada Victoria CAPITAL MARKETS DAY 25 JANUARY 2018 CAPITAL Portada Victoria MARKETS DAY 25 JANUARY 2018 Presentation to Shareholders Held at Keraben To provide further information on the recently acquired

More information

ICON plc. 10th Jan Ciaran Murray CEO Steve Cutler CEO Designate. JP Morgan 35TH Annual Healthcare

ICON plc. 10th Jan Ciaran Murray CEO Steve Cutler CEO Designate. JP Morgan 35TH Annual Healthcare ICON plc Ciaran Murray CEO Steve Cutler CEO Designate JP Morgan 35TH Annual Healthcare 10th Jan 2017 Forward Looking Statement Certain statements will be forward looking statements. Actual results may

More information

Corporate Philosophy and Vision, Brand Mark, Business Management Goals and Other Policies of Mitsubishi Tanabe Pharma Corporation

Corporate Philosophy and Vision, Brand Mark, Business Management Goals and Other Policies of Mitsubishi Tanabe Pharma Corporation May 16, 2007 Press Release Tanabe Seiyaku Co., Ltd. Mitsubishi Pharma Corporation Corporate Philosophy and Vision, Brand Mark, Business Management Goals and Other Policies of Mitsubishi Tanabe Pharma Corporation

More information

National Foundation for Women Legislators Annual Meeting September 12, 2015 Tara Ryan Vice President, State Government Advocacy

National Foundation for Women Legislators Annual Meeting September 12, 2015 Tara Ryan Vice President, State Government Advocacy From Hope to Cures: The Value of Biopharmaceutical Innovation National Foundation for Women Legislators Annual Meeting September 12, 2015 Tara Ryan Vice President, State Government Advocacy HIV/AIDS: Then

More information

FOR ANIMALS FOR HEALTH FOR YOU

FOR ANIMALS FOR HEALTH FOR YOU FOR ANIMALS FOR HEALTH FOR YOU WE HAVE A SINGULAR FOCUS ON ANIMAL HEALTH Zoetis is the world leader in animal health. We discover, develop, manufacture and market veterinary medicines and vaccines, complemented

More information

Genomics Market Share, Size, Analysis, Growth, Trends and Forecasts to 2024 Hexa Research

Genomics Market Share, Size, Analysis, Growth, Trends and Forecasts to 2024 Hexa Research Genomics Market Share, Size, Analysis, Growth, Trends and Forecasts to 2024 Hexa Research " Increasing usage of novel genomics techniques and tools, evaluation of their benefit to patient outcome and focusing

More information

Edwards Lifesciences

Edwards Lifesciences Edwards Lifesciences Heart Valve Therapy Donald E. Bobo Corporate Vice President, Surgical Heart Valves 1 Strong Outlook for Surgical Heart Valve Therapy Global patient trends and innovation expected to

More information

From discussion to implementation: How to negotiate and implement a risk-sharing agreement

From discussion to implementation: How to negotiate and implement a risk-sharing agreement July 2017 From discussion to implementation: How to negotiate and implement a risk-sharing agreement At the table with payers and manufacturers Background The groundswell of interest in value-based drug

More information

AMBITION TO LEAD THE ZERO CARBON TRANSITION

AMBITION TO LEAD THE ZERO CARBON TRANSITION Press release 28 February 2019 ENGIE Capital Markets Day AMBITION TO LEAD THE ZERO CARBON TRANSITION FOCUSED STRATEGY TARGETING CORPORATES AND LOCAL GOVERNMENTS SELECTIVE INVESTMENTS TO DRIVE ACCELERATED

More information

Health Care Worldwide. Crédit Suisse Global Credit Products Conference October 1, Barcelona

Health Care Worldwide. Crédit Suisse Global Credit Products Conference October 1, Barcelona Health Care Worldwide Crédit Suisse Global Credit Products Conference October 1, 2015 - Barcelona Safe Harbor Statement This presentation contains forward-looking statements that are subject to various

More information

Implementation of Portfolio Strategy in Today s Global Economy

Implementation of Portfolio Strategy in Today s Global Economy Implementation of Portfolio Strategy in Today s Global Economy Kurtis Klein, RPh Vice President Corporate Strategy & Business Development ALCON LABORATORIES, INC. Agenda Corporate overview Alcon Laboratories

More information

JEFFERIES 2015 GLOBAL HEALTHCARE CONFERENCE JUNE 3, 2015 NACHUM HOMI SHAMIR PRESIDENT AND CHIEF EXECUTIVE OFFICER

JEFFERIES 2015 GLOBAL HEALTHCARE CONFERENCE JUNE 3, 2015 NACHUM HOMI SHAMIR PRESIDENT AND CHIEF EXECUTIVE OFFICER JEFFERIES 2015 GLOBAL HEALTHCARE CONFERENCE JUNE 3, 2015 NACHUM HOMI SHAMIR PRESIDENT AND CHIEF EXECUTIVE OFFICER SAFE HARBOR STATEMENT Certain statements made during the course of this presentation may

More information